BerganKDV Wealth Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-2
| Closed | -$401 | – | 872 |
|
2023
Q1 | $401 | Sell |
2
-2
| -50% | -$401 | ﹤0.01% | 990 |
|
2022
Q4 | $951 | Buy |
4
+2
| +100% | +$476 | ﹤0.01% | 886 |
|
2022
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 959 |
|
2022
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 966 |
|
2022
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 991 |
|
2021
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 1048 |
|
2021
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 1030 |
|
2021
Q2 | $0 | Buy |
+2
| New | – | ﹤0.01% | 979 |
|
2020
Q3 | – | Sell |
-19
| Closed | -$3K | – | 907 |
|
2020
Q2 | $3K | Buy |
+19
| New | +$3K | ﹤0.01% | 682 |
|